Business Insider20h
Rocket Pharmaceuticals: Strong Buy Rating Backed by Promising AAV and LV Franchise Developments and Solid Financial Position
Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The firm’s clinical program is a LVV-based gene therapy for ...
Positive Outlook for Rocket Pharmaceuticals Amidst Significant Trial Progress and Regulatory Engagement
TD Cowen analyst Tyler Van Buren has maintained their bullish stance on RCKT stock, giving a Buy rating today. Tyler Van Buren has given his ...
Ventures Africa8h
National Basketball Association (NBA) Africa and Agence Française de Développement (AFD) Launch Youth Development Program in Senegal
Former NBA Player and 2015 FIBA AfroBasket Champion Olumide Oyedeji Attends Launch – NBA Africa ( and Agence Française de ...